CD44 and breast carcinoma: Importantly, CD44+CD24−/lowESA+ cells, ALDH+ cells and mammosphere-forming cells isolated from breast cancer cell lines are also enriched for self-renewal capacity and tumorigenic potential in xenograft tumor assays [15, 16].